会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • 작약 종자 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물
    • 包含提取物的活性成分的药物组合物,其分离物或其分离的化合物作为活性成分
    • KR1020120016861A
    • 2012-02-27
    • KR1020100079356
    • 2010-08-17
    • 한국화학연구원
    • 김영섭유시용홍경식최춘환차미란박우규
    • A61K36/65A61K31/343A61P25/28A61P25/00
    • A61K36/65A23L29/035A23V2200/322A61K31/216A61K31/343A61K2236/33
    • PURPOSE: A pharmaceutical composition containing Paeonia lactiflora seed extract, fraction thereof, or compound isolated from the same is provided to suppress BACE-1 activity and to treat and prevent neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains Paeonia lactiflora seed extract as an active ingredient. The neurodegenerative diseases include Alzheimer's dieses, Parkinsons's disease, progressive supranuclear palsy. The extract is prepared using water, alcohol of C1-C4, or mixture solvent thereof. The pharmaceutical composition contains Paeonia lactiflora seed fraction as an active ingredient. The pharmaceutical composition also contains compounds as an active ingredient. The method for preparing the compounds comprises: a step of adding water, C1-C3 alcohol, or mixture thereof to the Paeonia lactiflora seeds to prepare Paeonia lactiflora seed extract; a step of fractioning the extract with water, dichloromethane, and ethyl acetate to prepare a fraction; a step of performing silicagel column chromatography of the fraction.
    • 目的:提供含有芍药提取物,其部分或从其分离的化合物的药物组合物以抑制BACE-1活性并治疗和预防神经变性疾病。 构成:用于预防或治疗神经变性疾病的药物组合物含有芍药种子提取物作为活性成分。 神经变性疾病包括阿尔茨海默氏病,帕金森氏病,进行性核上性麻痹。 萃取液用水,C1-C4的醇或其混合溶剂制备。 该药物组合物含有作为活性成分的芍药芍药种子。 药物组合物还含有作为活性成分的化合物。 制备化合物的方法包括:将水,C1-C3醇或其混合物加入到芍药种子中以制备芍药提取物的步骤; 用水,二氯甲烷和乙酸乙酯分级提取物以制备级分的步骤; 进行该级分的硅胶柱色谱的步骤。
    • 7. 发明公开
    • 포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물
    • 用于治疗包含来自葡萄膜干燥分离的抑制剂衍生物的癌症的药物组合物
    • KR1020120116115A
    • 2012-10-22
    • KR1020110033674
    • 2011-04-12
    • 한국화학연구원국민대학교산학협력단
    • 최상운유시용김영섭최춘환최연희차미란김영균
    • A61K31/045A61K31/05A61K36/87A23L33/10A23L33/105A23L2/52
    • A61K31/045A23L2/52A23L33/10A23L33/105A61K31/05A61K36/87A61K2300/00
    • PURPOSE: An anticancer drug composition including resveratrol derivative compound separated from grape stem shell is provided to prevent and treat all kinds of cancers including lung cancer, ovarian cancer, melanoma, central nervous system tumor, colon carcinoma, and leukemia. CONSTITUTION: An anticancer drug composition includes vitisinol C, vitisinol E, cis-vitisin A, vitisin B, vitisin C, a pharmaceutically acceptable salt and isomer or a mixture thererof, and grape stem shell extract including thereof as an active ingredient. The grape stem shell extract is obtained by extracting methanol, methanol aqueous solution, ethanol, ethanol aqueous solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma or colon carcinoma. A health enhancement food having cancer cell growth inhibition efficacy contains vitisinol C, vitisinol E, cis-viticin A, viticin B, viticin C, pharmaceutically acceptable salt, isomer or a mixture thereof, and grapes stem shell extract including the same. The food is in beverage form. The grape stem shell extract is obtained by the following steps: extracting the grape stem shell by methanol and suspending the obtained extract in distilled water; partitioning thereof by dichloromethane; and extracting the obtained water layer by ethyl acetate.
    • 目的:提供包括从葡萄茎壳分离的白藜芦醇衍生物化合物的抗癌药物组合物,用于预防和治疗各种癌症,包括肺癌,卵巢癌,黑素瘤,中枢神经系统肿瘤,结肠癌和白血病。 构成:抗癌药物组合物包括维生素C,维生素E,顺式维生素A,维生素B,维生素C,其药学上可接受的盐和异构体或其混合物,以及包含它们的葡萄茎壳提取物作为活性成分。 葡萄茎壳提取物是通过提取甲醇,甲醇水溶液,乙醇,乙醇水溶液,丁醇,二氯甲烷,乙酸乙酯或其混合物得到的。 癌症是肺癌,卵巢癌,黑素瘤或结肠癌。 具有癌细胞生长抑制作用的健康增强食品包含维生素C,维生素E,顺式维生素A,维生素B,维生素C,其药学上可接受的盐,异构体或其混合物,以及包含其的葡萄茎壳提取物。 食物是饮料形式。 通过以下步骤获得葡萄茎壳提取物:用甲醇萃取葡萄茎壳,将得到的提取物悬浮于蒸馏水中; 用二氯甲烷分配; 并用乙酸乙酯萃取得到的水层。